サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：乳房病変局在化法の市場：世界の産業動向、シェア、規模、成長、機会、予測2023-2028
市場調査レポート
商品コード
1207022

乳房病変局在化法の市場：世界の産業動向、シェア、規模、成長、機会、予測2023-2028

Breast Lesion Localization Methods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
乳房病変局在化法の市場：世界の産業動向、シェア、規模、成長、機会、予測2023-2028
出版日: 2023年01月31日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

乳房病変局在化法の世界市場規模は、2022年に11億280万米ドルに達しました。今後、IMARCグループは、2023年から2028年の間に10.1%の成長率（CAGR）を示し、2028年までに20億1,850万米ドルに達すると予測しています。

乳房病変局在化法とは、病気や怪我によって引き起こされる乳房組織の異常な変化（乳房病変とも呼ばれる）を検出するために採用される様々な処置のことを指します。一般的に使用される方法には、ワイヤーローカライゼーション、カーボンマーキング、ラジオガイド下病変局在診断（ROLL）、放射性シードローカライゼーション（RSL）、磁気シードローカライゼーション（Magseed）、術中超音波診断（IOUS）などがあります。これらの技術は、医師やヘルスケア専門家が十分な情報を得た上で意思決定を行い、患者にとって理想的な治療や手術を決定するのに役立っています。外科手術、イメージング、バイオメディカル技術の進歩に伴い、乳房病変局在化法は大幅に進化しており、現在、ヘルスケア分野における需要を促進しています。

乳房病変局在化法の市場動向

  • ライフスタイルの変化や不健康な食生活別乳がん患者の大幅な増加が、市場成長の主な要因となっています。また、乳腺摘出術や外科的生検を必要とする患者の増加により、標的病変を正確に除去するための乳房病変局在化法の需要が高まっています。その他、各国の行政機関は、乳がんの早期発見の利点に関する意識を広めるために、好ましい取り組みを行っています。例えば、オーストラリア政府は、2年に1度、50～74歳の女性に無料でマンモグラフィーを提供する全国的な乳がん検診プログラム「BreastScreen Australia」を開始しました。これは、乳がん診断、生検、その他の関連医療処置に対する政府および民間の償還政策の増加や、主要企業による革新的な乳房病変局在診断装置の発売と相まって、市場成長の触媒となっているのです。さらに、研究開発（R&D）活動への多額の投資が、市場参加者に有利な機会を提供しています。その他、バストアップなどの美容整形手術を受ける人の増加、ヘルスケアインフラの改善、技術の進歩、消費者の医療費支出の増加なども、市場の見通しを明るくしている要因です。

主な市場セグメンテーション

  • IMARC Groupは、世界の乳房病変局在化法市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、市場をタイプ、用途、エンドユーザーに基づいて分類しています。

タイプ別の内訳

  • ワイヤーローカライゼーション
  • 放射性同位元素ローカライゼーション
  • 磁気トレーサー局在化
  • その他

用途別内訳

  • 腫瘍同定
  • センチネル・リンパ節同定
  • ルンペクトミー
  • 乳房切除術

エンドユーザー別内訳

  • 病院
  • 診断センター
  • オンコロジークリニック
  • 外来手術センター

地域別内訳

  • 北米
  • 米国
  • カナダ
  • アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
  • 中東とアフリカ

本レポートで回答した主な質問

  • 1.2022年の世界の乳房病変局在化法市場規模は？
  • 2.2023-2028年の世界の乳房病変局在化法市場の予想成長率は？
  • 3.乳房病変局在化法の世界市場を牽引する主要因は何か？
  • 4.COVID-19が世界の乳房病変局在化法市場に与えた影響は？
  • 5.乳房病変局在化法の世界市場のタイプ別区分は？
  • 6.乳房病変局在化法の世界市場の用途別区分は？
  • 7.乳房病変局在化法の世界市場のエンドユーザー別区分は？
  • 8.乳房病変局在化法の世界市場における主要地域は？
  • 9.乳房病変局在化法の世界市場における主要なプレイヤー/企業はどこか？

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 乳房病変局在化法の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 タイプ別市場内訳

  • ワイヤローカライゼーション
    • 市場動向
    • 市場予測
  • 放射性同位元素ローカライゼーション
    • 市場動向
    • 市場展望
  • 磁気トレーサーのローカライゼーション
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 用途別市場内訳

  • 腫瘍同定
    • 市場動向
    • 市場予測
  • センチネルリンパ節同定装置
    • 市場動向
    • 主要セグメント
      • ルンペクトミー
      • 乳房切除術
    • 市場予測

第8章 エンドユーザー別市場内訳

  • 病院
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測
  • オンコロジークリニック
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場展望

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場展望
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場展望
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場展望
    • 韓国市場
      • 市場動向
      • 市場展望
    • オーストラリア
      • 市場動向
      • 市場展望
    • インドネシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場展望
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場展望
    • スペイン
      • 市場動向
      • 市場展望
    • ロシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場展望
    • メキシコ
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競争情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Argon Medical Devices Inc.
    • Becton Dickinson and Company
    • Cook Group Incorporated
    • CP Medical Inc.（Theragenics Corporation）
    • Endomagnetics Ltd.
    • Hologic Inc.
    • IsoAid LLC
    • IZI Medical Products（Landauer Inc）
    • Laurane Medical LLC
    • Leica Biosystems Nussloch GmbH（Danaher Corporation）
    • Merit Medical Systems Inc.
    • Sterylab S.r.l
図表

List of Figures

  • Figure 1: Global: Breast Lesion Localization Methods Market: Major Drivers and Challenges
  • Figure 2: Global: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Breast Lesion Localization Methods Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Breast Lesion Localization Methods Market: Breakup by Usage (in %), 2022
  • Figure 6: Global: Breast Lesion Localization Methods Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Breast Lesion Localization Methods Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Breast Lesion Localization Methods (Wire Localization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Breast Lesion Localization Methods (Wire Localization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Breast Lesion Localization Methods (Radioisotope Localization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Breast Lesion Localization Methods (Radioisotope Localization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Breast Lesion Localization Methods (Magnetic Tracers Localization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Breast Lesion Localization Methods (Magnetic Tracers Localization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Breast Lesion Localization Methods (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Breast Lesion Localization Methods (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Breast Lesion Localization Methods (Tumor Identification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Breast Lesion Localization Methods (Tumor Identification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Breast Lesion Localization Methods (Sentinel Lymph Node Identification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Breast Lesion Localization Methods (Sentinel Lymph Node Identification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Breast Lesion Localization Methods (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Breast Lesion Localization Methods (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Breast Lesion Localization Methods (Diagnostic Centres) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Breast Lesion Localization Methods (Diagnostic Centres) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Breast Lesion Localization Methods (Oncology Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Breast Lesion Localization Methods (Oncology Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Breast Lesion Localization Methods (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Breast Lesion Localization Methods (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Breast Lesion Localization Methods Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Breast Lesion Localization Methods Industry: SWOT Analysis
  • Figure 78: Global: Breast Lesion Localization Methods Industry: Value Chain Analysis
  • Figure 79: Global: Breast Lesion Localization Methods Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Breast Lesion Localization Methods Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Usage (in Million US$), 2023-2028
  • Table 4: Global: Breast Lesion Localization Methods Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Breast Lesion Localization Methods Market: Competitive Structure
  • Table 7: Global: Breast Lesion Localization Methods Market: Key Players
目次
Product Code: SR1323A494_Report

The global breast lesion localization methods market size reached US$ 1,102.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,018.5 Million by 2028, exhibiting a growth rate (CAGR) of 10.1% during 2023-2028.

Breast lesion localization methods refer to various procedures employed to detect abnormal changes in the breast tissue, also called a breast lesion, caused due to a disease or injury. Some commonly used methods include wire localization, carbon marking, radio-guided occult lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization (Magseed), and intraoperative ultrasound (IOUS). These techniques assist doctors and healthcare professionals in making informed decisions and determining the ideal treatment or surgery for the patient. With advancements in surgical, imaging and biomedical technology, breast lesion localization methods have significantly evolved, which is presently driving their demand in the healthcare sector.

Breast Lesion Localization Methods Market Trends:

  • A significant increase in breast cancer cases due to changing lifestyles, and unhealthy diets represents the primary factor driving the market growth. Besides this, the growing number of patients requiring lumpectomy and surgical biopsy procedures is augmenting the demand for breast lesion localization methods to ensure accurate removal of the target lesion. Additionally, the governing agencies of various countries are taking favorable initiatives to spread awareness regarding the benefits of early detection of breast cancer. For instance, the Government of Australia launched BreastScreen Australia, a national breast cancer screening program that provides a free mammogram to women aged 50-74 every two years. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer diagnosis, biopsy and other related medical procedures and the launch of innovative breast lesion localization devices by leading players, is catalyzing the market growth. Furthermore, heavy investments in research and development (R&D) activities are offering lucrative opportunities to the market players. Other factors, including the rising number of individuals undergoing cosmetic surgeries like breast enhancement, improving healthcare infrastructure, technological advancements, and increasing consumer healthcare spending, are also creating a positive market outlook.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global breast lesion localization methods market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, usage and end user.

Breakup by Type:

  • Wire Localization
  • Radioisotope Localization
  • Magnetic Tracers Localization
  • Others

Breakup by Usage:

  • Tumor Identification
  • Sentinel Lymph Node Identification
  • Lumpectomy
  • Mastectomy

Breakup by End User:

  • Hospitals
  • Diagnostic Centres
  • Oncology Clinics
  • Ambulatory Surgical Centers

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Becton Dickinson and Company, Cook Group Incorporated, CP Medical Inc. (Theragenics Corporation), Endomagnetics Ltd., Hologic Inc., IsoAid LLC, IZI Medical Products (Landauer Inc), Laurane Medical LLC, Leica Biosystems Nussloch GmbH (Danaher Corporation), Merit Medical Systems Inc. and Sterylab S.r.l.

Key Questions Answered in This Report:

  • 1. What was the size of the global breast lesion localization methods market in 2022?
  • 2. What is the expected growth rate of the global breast lesion localization methods market during 2023-2028?
  • 3. What are the key factors driving the global breast lesion localization methods market?
  • 4. What has been the impact of COVID-19 on the global breast lesion localization methods market?
  • 5. What is the breakup of the global breast lesion localization methods market based on type?
  • 6. What is the breakup of the global breast lesion localization methods market based on the usage?
  • 7. What is the breakup of the global breast lesion localization methods market based on the end user?
  • 8. What are the key regions in the global breast lesion localization methods market?
  • 9. Who are the key players/companies in the global breast lesion localization methods market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Breast Lesion Localization Methods Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Wire Localization
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radioisotope Localization
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Magnetic Tracers Localization
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Usage

  • 7.1 Tumor Identification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Sentinel Lymph Node Identification
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Lumpectomy
      • 7.2.2.2 Mastectomy
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Centres
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Oncology Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Ambulatory Surgical Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Argon Medical Devices Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cook Group Incorporated
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 CP Medical Inc. (Theragenics Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Endomagnetics Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Hologic Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 IsoAid LLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 IZI Medical Products (Landauer Inc)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Laurane Medical LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Leica Biosystems Nussloch GmbH (Danaher Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Merit Medical Systems Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sterylab S.r.l
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio